CoChat

Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer

Open access
Fuentes-Mattei, Enrique, Velazquez-Torres, Guermarie, Phan, Liem, Zhang, Fanmao, Chou, Ping-Chieh, Shin, Ji-Hyun, Choi, Hyun Ho, Chen, Jiun-Sheng, Zhao, Ruiying, Chen, Jian, Gully, Chris, Carlock, Colin, Qi, Yuan, Zhang, Ya, Wu, Yun, Esteva, Francisco J., Luo, Yongde, McKeehan, Wallace L., Ensor, Joe, Hortobagyi, Gabriel N., Pusztai, Lajos, Fraser Symmans, W., Lee, Mong-Hong, Jim Yeung, Sai-Ching · 2014 · JNCI: Journal of the National Cancer Institute
Cited by 114

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Obesity increases the risk of cancer death among postmenopausal women with estrogen receptor-positive (ER+) breast cancer, but the direct evidence for the mechanisms is lacking. The purpose of this study is to demonstrate direct evidence for the mechanisms mediating this epidemiologic phenomenon. METHODS: We analyzed transcriptomic profiles of pretreatment biopsies from a prospective cohort of 137 ER+ breast cancer patients. We generated transgenic (MMTV-TGFα;A (y) /a) and orthotopic/syngeneic (A (y) /a) obese mouse models to investigate the effect of obesity on tumorigenesis and tumor progression and to determine biological mechanisms using whole-genome transcriptome microarrays and protein analyses. We used a coculture system to examine the impact of adipocytes/adipokines on breast cancer cell proliferation. All statistical tests were two-sided. RESULTS: Functional transcriptomic analysis of patients revealed the association of obesity with 59 biological functional changes (P < .05) linked to cancer hallmarks. Gene enrichment analysis revealed enrichment of AKT-target genes (P = .04) and epithelial-mesenchymal transition genes (P = .03) in patients. Our obese mouse models demonstrated activation of the AKT/mTOR pathway in obesity-accelerated mammary tumor growth (3.7- to 7.0-fold; P < .001; n = 6-7 mice per group). Metformin or everolimus can suppress obesity-induced secretion of adipokines and breast tumor formation and growth (0.5-fold, P = .04; 0.3-fold, P < .001, respectively; n = 6-8 mice per group). The coculture model revealed that adipocyte-secreted adipokines (eg, TIMP-1) regulate adipocyte-induced breast cancer cell proliferation and invasion. Metformin suppress adipocyte-induced cell proliferation and adipocyte-secreted adipokines in vitro. CONCLUSIONS: Adipokine secretion and AKT/mTOR activation play important roles in obesity-accelerated breast cancer aggressiveness in addition to hyperinsulinemia, estrogen signaling, and inflammation. Metformin and everolimus have potential for therapeutic interventions of ER+ breast cancer patients with obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/dju158

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 114

Metadata

Authors
Fuentes-Mattei, E., Velazquez-Torres, G., Phan, L., Zhang, F., Chou, P.-C., Shin, J.-H., Choi, H. H., Chen, J.-S., Zhao, R., Chen, J., Gully, C., Carlock, C., Qi, Y., Zhang, Y., Wu, Y., Esteva, F. J., Luo, Y., McKeehan, W. L., Ensor, J., Hortobagyi, G. N., Pusztai, L., Fraser Symmans, W., Lee, M.-H., & Jim Yeung, S.-C.
Venue
JNCI: Journal of the National Cancer Institute
Published
2014-06
Volume
106
Issue
7
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2164408432
Cited by
114
References
3
FWCI
6.46
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer. https://app.cochat.ai/papers/10.1093/jnci/dju158
The paper
Fuentes-Mattei, E., Velazquez-Torres, G., Phan, L., Zhang, F., Chou, P.-C., Shin, J.-H., Choi, H. H., Chen, J.-S., Zhao, R., Chen, J., Gully, C., Carlock, C., Qi, Y., Zhang, Y., Wu, Y., Esteva, F. J., Luo, Y., McKeehan, W. L., Ensor, J., . . . Jim Yeung, S.-C. (2014). Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/dju158

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.